Showing results (1131-1140 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|September 27, 2023
Exercise changes the intrahepatic immune cell profile and inhibits the progression of nonalcoholic steatohepatitis in a mouse modelYuriko Tsutsui, Taizo Mori, Sachiyo Yoshio, et al.Hepatology Communications|July 20, 2023
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinomaTomoharu Yamada, Naoto Fujiwara, Naoto Kubota, et al.Hepatology Communications|July 3, 2023
Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosisJaideep Behari, Amir Gougol, Renwei Wang, et al.Hepatology Communications|September 14, 2020
Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASHDavide Povero, Hirokazu Yamashita, Wenhua Ren, et al.Hepatology Communications|September 14, 2020
Targeted Inhibition of Purine Metabolism Is Effective in Suppressing Hepatocellular Carcinoma ProgressionYong Chun Chong, Tan Boon Toh, Zhiling Chan, et al.Hepatology Communications|January 8, 2020
Stathmin 1 Induces Murine Hepatocyte Proliferation and Increased Liver MassEnpeng Zhao, Yang Shen, Muhammad Amir, et al.Hepatology Communications|January 8, 2020
Circulating MicroRNA-122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLDNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.Hepatology Communications|January 8, 2020
Farnesoid X Receptor Agonism, Acetyl-Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH ModelBerangere Gapp, Marie Jourdain, Pauline Bringer, et al.Hepatology Communications|January 8, 2020
CorrectionHepatology Communications|October 7, 2020
Deficiency of miR-208a Exacerbates CCl4-Induced Acute Liver Injury in Mice by Activating Cell Death PathwaysShashi Bala, Charles D Calenda, Donna Catalano, et al.Pageof 179